ANTI-HCV AND LIVER-DISEASE IN ITALY IN THE LAST 10 YEARS

被引:0
|
作者
ALBERTI, A
TREMOLADA, F
BORTOLOTTI, F
DIODATI, G
FATTOVICH, G
REALDI, G
TAGGER, A
FERRONI, P
机构
[1] UNIV PADUA,MED CLIN 2,I-35100 PADUA,ITALY
[2] IST VIROL,MILAN,ITALY
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:644 / 644
页数:1
相关论文
共 50 条
  • [41] Recurrence of HCV infection in liver transplant patients: Evaluation of IgM Anti-HCV and IgM Anti-CMV
    Ceccherini-Nelli, L
    Giannotti, A
    Malizia, T
    Ciccorossi, P
    Olivieri, F
    Vanni, M
    Lico, S
    Campani, D
    Filipponi, F
    Brunetto, M
    Mosca, F
    Campa, M
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (03) : 1030 - 1031
  • [42] Liver histology in anti-HCV positive subjects with normal ALT levels
    Puoti, C
    Stati, T
    Magrini, A
    Rigato, P
    Romagnoli, G
    Rossi, P
    Montagnese, F
    Resta, S
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1997, 29 (04): : 383 - 384
  • [43] PREVALENCE OF ANTI-HCV IN PATIENTS WITH VARIOUS LIVER-DISEASES IN KOREA
    YOO, JY
    SHIN, HK
    PARK, CK
    CHUNG, KW
    SUN, HS
    CHUNG, WK
    DIBISCEGLIE, AM
    WAGGONER, JJ
    HOOFNAGLE, JH
    HEPATOLOGY, 1990, 12 (04) : 975 - 975
  • [44] Theoretical impact of an anti-HCV vaccine on the annual number of liver transplantation
    Chaib, Eleazar
    Franca de Oliveira, Maria Cristina
    Ferreira Galvao, Flavio Henrique
    Silva, Felipe Duarte
    Carneiro D'Albuquerque, Luiz Augusto
    Massad, Eduardo
    MEDICAL HYPOTHESES, 2010, 75 (03) : 324 - 327
  • [45] HCV VIREMIA AND GENOTYPES IN CHRONIC LIVER-DISEASE FROM SOUTHERN ITALY - RELATIONSHIP TO IFN OR CORTICOSTEROID TREATMENT
    MAGRIN, S
    CRAXI, A
    FABIANO, C
    MARINO, L
    FIORENTINO, G
    DIMARCO, V
    LOIACONO, O
    DIQUATTRO, O
    ALMASIO, P
    URDEA, MS
    WILBER, JH
    STUYVER, L
    PAGLIARO, L
    HEPATOLOGY, 1994, 19 (04) : I96 - I96
  • [46] RELATIONSHIP BETWEEN ALCOHOLIC LIVER-DISEASE AND HCV INFECTION
    TAKASE, S
    TAKADA, N
    SAWADA, M
    TSUTSUMI, M
    TAKADA, A
    ALCOHOL AND ALCOHOLISM, 1993, 28 : 77 - 84
  • [47] Plasma hydroxy metronidazole/metronidazole ratio in anti-HCV carriers with and without apparent liver disease.
    da Silva, CMF
    David, FL
    Muscará, MN
    Sousa, SS
    Ferraz, JGP
    de Nucci, G
    Polimeno, NC
    Pedrazzoli, J
    GASTROENTEROLOGY, 1998, 114 (04) : A1232 - A1232
  • [48] HCV INFECTION IN HBSAG POSITIVE CHRONIC LIVER-DISEASE
    FATUZZO, F
    MUGHINI, MT
    CACOPARDO, B
    LAROSA, R
    NIGRO, L
    LUPO, G
    BRUNO, S
    ZUCCARELLO, M
    CALTABIANO, E
    ZIPPER, F
    COSENTINO, S
    RUSSO, R
    NUNNARI, A
    ARCHIVES OF VIROLOGY, 1992, : 325 - 326
  • [49] THE LOCALIZATION OF HCV AND THE EXPRESSION OF FAS ANTIGEN IN THE LIVER OF HCV-RELATED CHRONIC LIVER-DISEASE
    OHISHI, M
    SAKISAKA, S
    KOGA, H
    SASATOMI, K
    KOJI, T
    NAKANE, PK
    NOGUCHI, K
    SATA, M
    TANIKAWA, K
    HEPATOLOGY, 1995, 22 (04) : 672 - 672
  • [50] MODULATION OF THE SEVERITY OF HCV RECURRENCE ON THE LIVER GRAFT BY ANTI-HCV IMMUNE RESPONSE IN HIV/HCV COINFECTED PATIENTS
    Samri, A.
    Roque-Afonso, A.
    Beran, O.
    Samuel, D.
    Autran, B.
    Duclos-Vallee, J. C.
    LIVER TRANSPLANTATION, 2008, 14 (07) : S242 - S243